Antibe Therapeutics Lists on TSX Venture Exchange - Video Summary on Investmentpitch.com
June 25, 2013 7:25 PM EDT | Source: InvestmentPitch Media
Vancouver, British Columbia--(Newsfile Corp. - June 25, 2013) - Antibe Therapeutics (TSXV: ATE) lists on the TSX Venture Exchange. The company completed an IPO offering of 3,868,000 shares at $0.55, raising $2,127,000 in gross proceeds, with Burgeonvest Bick Securities acting as lead agent for the offering.
InvestmentPitch.com has produced a "video news alert" which provides a brief overview of Antibe Therapeutics. If this link is not enabled, please visit www.InvestmentPitch.comand enter "Antibe" in the search box.
If you cannot view the video above, please visit:
http://www.investmentpitch.com/video/0_8rku8wkm/
Antibe originates, develops and out-licenses patent-protected new pharmaceuticals that are improved versions of existing drugs. These improvements are based on Nobel Prize-winning medical research highlighting the crucial role of gaseous mediators, which are chemical substances produced in the human body to regulate a range of fundamental cellular processes.
The company's drug design methodologies involve chemically linking an existing off-patent drug to an Antibe-patented, hydrogen sulfide-releasing molecule.
For medical conditions characterized by inflammation, pain or vascular dysfunction, the company's methodologies can efficiently produce improved versions of a number of existing drugs.
Notably, Antibe's products are themselves fully patent-protectable and benefit from the predictable toxicity and effectiveness profiles of the base drug.
Antibe's President & CEO Dan Legault, stated, "We are excited to be moving forward with the prospects of bringing significant medical benefits to patients worldwide."
The shares are currently trading at $0.55, and with 26.1 million shares outstanding, the company is capitalized at $14.4 million.
For more information about Antibe Therapeutics, please visit www.antibethera.com or contact Dan Legault at 416-473-4095 or by email at Dan@AntibeThera.com.
About InvestmentPitch
InvestmentPitch.com, a multimedia company that provides a combined solution for creating and hosting financial video content, and distributing it across multiple platforms to investors and financial professionals, specializes in producing short three minute videos based on significant news releases and research reports.
CONTACT:
InvestmentPitch.com
Barry Morgan, CFO
bmorgan@investmentpitch.com